Evidence map›Paper›PMID 42331809›Full record

ArticleNature communications2026

Hierarchical interplay between H3K27ac and H3K4me3 in transcriptional regulation.

Chenwei Zhou, Chanjuan Dong, Weiye Zhao, Fu-Sen Liang

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Chenwei ZhouDepartment of Chemistry, Case Western Reserve University, Cleveland, OH, USA.
Chanjuan DongDepartment of Chemistry, Case Western Reserve University, Cleveland, OH, USA.
Weiye ZhaoDepartment of Chemistry, Case Western Reserve University, Cleveland, OH, USA.
Fu-Sen LiangDepartment of Chemistry, Case Western Reserve University, Cleveland, OH, USA. fxl240@case.edu.ORCID http://orcid.org/0000-0002-1793-0824

Funding

"Developing A Comprehensive Toolkit for Chemical Inducible Epigenome Remodeling"R01GM143256 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI LIANG, FU-SEN · 2022 to 2025
$1.3M
NIGMS NIH HHS R01 GM143256U.S. Department of Health & Human Services | National Institutes of Health (NIH) R01GM143256
6 · The paper itself

Abstract

H3K27ac and H3K4me3 are enriched at transcriptional start sites and have been implicated in transcription. However, how these marks concertedly regulate transcription is not fully understood. Here, we develop a dual chemically inducible CRISPR/dCas9-based epigenome editing system that enables independent, temporal and transcription stage-specific modulation of H3K27ac and H3K4me3 at a specific gene locus. Stage-specific removal of H3K4me3 impairs RNA polymerase II recruitment, increases promoter-proximal pausing, reduces productive elongation, and accelerates mRNA decay via increased m⁶A deposition. Losing both H3K27ac and H3K4me3 rapidly abolishes transcriptional activity, while preserving H3K4me3 without H3K27ac can partially sustain transcription. These findings reveal a functional hierarchy and interdependence between H3K27ac and H3K4me3 in different transcription stages at the tested gene loci. This versatile tool will contribute to the functional dissection of the temporal dynamics of chromatin modifications in gene regulation.

Indexed as

Gene Expression RegulationHistonesTranscription, GeneticAnimalsChromatinCRISPR-Cas SystemsEpigenome EditingHumansPromoter Regions, GeneticRNA Polymerase IIRNA StabilityChromatinhistone H3 trimethyl Lys4HistonesRNA Polymerase II

Identifiers

PMID42331809
PMCPMC13443676

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.